| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI25151 |
| P8608 | Fatcat ID | release_kaxzt4w27zffde7d6avdesj26a |
| P932 | PMC publication ID | 1280967 |
| P698 | PubMed publication ID | 16284649 |
| P50 | author | Stefan Bilz | Q51092222 |
| Gerald I. Shulman | Q52509909 | ||
| Katsutaro Morino | Q57020116 | ||
| Kitt Falk Petersen | Q65055037 | ||
| Sylvie Dufour | Q109941922 | ||
| Douglas Befroy | Q114424629 | ||
| Susanne Neschen | Q114429537 | ||
| Saki Sono | Q114735233 | ||
| Marc Pypaert | Q114735255 | ||
| P2093 | author name string | Morris F White | |
| Jared Frattini | |||
| Nadine Shatzkes | |||
| P2860 | cites work | AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation | Q24541475 |
| Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins | Q24561604 | ||
| Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | Q24629603 | ||
| Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
| Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action | Q28199220 | ||
| Prevention of fat-induced insulin resistance by salicylate | Q28345600 | ||
| Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes | Q28369463 | ||
| Mechanisms of fatty acid-induced inhibition of glucose uptake | Q28369732 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity | Q29614241 | ||
| Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes | Q29614548 | ||
| Cellular mechanisms of insulin resistance | Q29619549 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity | Q33834971 | ||
| The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes | Q34370790 | ||
| Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats | Q34975588 | ||
| Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts | Q35147530 | ||
| The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle | Q36804318 | ||
| Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. | Q38342426 | ||
| Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes | Q42441787 | ||
| Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment | Q44007240 | ||
| Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha | Q44043178 | ||
| Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes | Q45199109 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. | Q51565080 | ||
| Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. | Q51571877 | ||
| Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. | Q55033199 | ||
| Quantitative analysis of total mitochondrial DNA: Competitive polymerase chain reaction versus real-time polymerase chain reaction | Q61794052 | ||
| A short questionnaire for the measurement of habitual physical activity in epidemiological studies | Q70501617 | ||
| A microfluorometric method for the determination of free fatty acids in plasma | Q71689514 | ||
| Glucose metabolism during the menstrual cycle. Assessment with the euglycemic, hyperinsulinemic clamp | Q72831976 | ||
| Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function | Q73019421 | ||
| Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo | Q77755584 | ||
| Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade | Q77795070 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| phosphorylation | Q242736 | ||
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 3587-3593 | |
| P577 | publication date | 2005-11-10 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents | |
| P478 | volume | 115 |
| Q36720516 | "Deficiency" of mitochondria in muscle does not cause insulin resistance |
| Q42519232 | A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus |
| Q30405658 | A novel MitoTimer reporter gene for mitochondrial content, structure, stress, and damage in vivo. |
| Q36528537 | AMP-activated protein kinase signaling in metabolic regulation |
| Q34008821 | Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1 |
| Q36499679 | Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets |
| Q36805439 | Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity |
| Q28484573 | Activity-based protein profiling reveals mitochondrial oxidative enzyme impairment and restoration in diet-induced obese mice |
| Q43074217 | Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle |
| Q46105664 | Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons |
| Q36603344 | Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans |
| Q54979932 | Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12. |
| Q35233393 | Alteration of mitochondrial function in adult rat offspring of malnourished dams |
| Q30409518 | Altered body composition and energy expenditure but normal glucose tolerance among humans with a long-chain fatty acid oxidation disorder. |
| Q54671549 | Altered hepatic insulin signalling in male offspring of obese mice. |
| Q34257049 | Altered mitochondrial function and oxidative stress in leukocytes of anorexia nervosa patients. |
| Q33996111 | Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes |
| Q37337564 | Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice |
| Q41953306 | Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways |
| Q37351106 | An acetylation rheostat for the control of muscle energy homeostasis |
| Q39905953 | Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control |
| Q34180196 | Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells. |
| Q37112535 | Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance |
| Q99708919 | Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance? |
| Q46745043 | Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. |
| Q34796073 | Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy |
| Q36854842 | Association of blood lactate with carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study |
| Q34354390 | Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. |
| Q46333323 | Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects. |
| Q46358970 | Association of lactate with blood pressure before and after rapid weight loss |
| Q33959129 | Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes |
| Q36653911 | BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q37247001 | Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus. |
| Q36968690 | Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study |
| Q53684282 | Body composition and cardiometabolic health: the need for novel concepts. |
| Q42800055 | Brain energy metabolism parameters in an animal model of diabetes |
| Q40174504 | C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. |
| Q28573833 | Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle |
| Q46851086 | Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment |
| Q35829203 | Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns |
| Q48309267 | Childhood obesity and endocrine disrupting chemicals. |
| Q89736197 | Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes |
| Q58769586 | Chronic Exercise Improves Mitochondrial Function and Insulin Sensitivity in Brown Adipose Tissue |
| Q34502139 | Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle |
| Q34597594 | Chronically elevated glucose compromises myocardial mitochondrial DNA integrity by alteration of mitochondrial topoisomerase function |
| Q42700646 | Clk2 and B56β mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt. |
| Q42953342 | Comparison of in vivo postexercise phosphocreatine recovery and resting ATP synthesis flux for the assessment of skeletal muscle mitochondrial function. |
| Q33526750 | Compensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats |
| Q37423667 | Contribution of a first-degree family history of diabetes to increased serum adipocyte fatty acid binding protein levels independent of body fat content and distribution |
| Q39562912 | Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats |
| Q33621890 | Current views on type 2 diabetes |
| Q51363122 | Decreased peripheral blood mitochondrial DNA content is related to HbA1c, fasting plasma glucose level and age of onset in type 2 diabetes mellitus. |
| Q33589062 | Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity |
| Q33785779 | Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng |
| Q46507502 | Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance |
| Q88924939 | Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer |
| Q38015903 | Delivery to mitochondria: a narrower approach for broader therapeutics |
| Q80085805 | Development of type 2 diabetes in children and adolescents |
| Q38219740 | Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role? |
| Q35964800 | Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance |
| Q34109119 | Diacylglycerol-mediated insulin resistance |
| Q37329874 | Diagnosis and management of common chronic metabolic complications in HIV-infected patients |
| Q38171358 | Dietary stimulators of the PGC-1 superfamily and mitochondrial biosynthesis in skeletal muscle. A mini-review |
| Q57713559 | Dietary supplementation with vitamin E and C attenuates dexamethasone-induced glucose intolerance in rats |
| Q33386855 | Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice |
| Q40245739 | Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. |
| Q34370965 | Disordered lipid metabolism and the pathogenesis of insulin resistance |
| Q33765953 | Do mitochondria care about insulin resistance? |
| Q34625767 | Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes? |
| Q38674524 | Drosophila melanogaster: An emerging model of transgenerational effects of maternal obesity |
| Q36764954 | ESCI Award 2006. Mitochondrial function and endocrine diseases |
| Q21285128 | Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions |
| Q56967616 | Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle |
| Q43181470 | Effect of 10 days of bedrest on metabolic and vascular insulin action: a study in individuals at risk for type 2 diabetes. |
| Q37175109 | Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its Mechanism |
| Q36056827 | Effect of aging on muscle mitochondrial substrate utilization in humans |
| Q36030804 | Effect of limb demand ischemia on autophagy and morphology in mice. |
| Q43091574 | Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients |
| Q88051558 | Effects of exercise in a cold environment on transcriptional control of PGC-1α |
| Q33669722 | Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice. |
| Q37439819 | Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction |
| Q50048688 | Elevated Medium Chain-Acylcarnitines are Associated with Gestational Diabetes, and Early Progression to Type-2 Diabetes, and Induce Pancreatic β-Cell Dysfunction. |
| Q35029353 | Elevated muscle TLR4 expression and metabolic endotoxemia in human aging |
| Q50940302 | Elevated whole blood viscosity is associated with insulin resistance and non-alcoholic fatty liver. |
| Q35579562 | Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state |
| Q98778835 | Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats |
| Q33901576 | Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications |
| Q95660532 | Enhanced skeletal muscle insulin sensitivity after acute resistance-type exercise is upregulated by rapamycin-sensitive mTOR complex 1 inhibition |
| Q37466859 | Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy |
| Q36431215 | Etiology of insulin resistance |
| Q34974105 | Etiology of insulin resistance in youth with type 2 diabetes |
| Q59335959 | Exercise as 'precision medicine' for insulin resistance and its progression to type 2 diabetes: a research review |
| Q27021167 | Exercise as an intervention to improve metabolic outcomes after intrauterine growth restriction |
| Q57545095 | Exercise early in life in rats born small does not normalize reductions in skeletal muscle PGC-1α in adulthood |
| Q51083138 | Exercise training-induced improvement in skeletal muscle PGC-1α-mediated fat metabolism is independent of dietary glycemic index. |
| Q51823337 | Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise. |
| Q33909948 | Fetal muscle development, mesenchymal multipotent cell differentiation, and associated signaling pathways. |
| Q34041888 | Fetal programming and metabolic syndrome |
| Q38164574 | Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology. |
| Q35041039 | G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. |
| Q30411123 | GLP-1 (7-36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles |
| Q45979115 | Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients. |
| Q59072667 | Genetic Dissection of the Physiological Role of Skeletal Muscle in Metabolic Syndrome |
| Q28756871 | Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle |
| Q34615307 | Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. |
| Q89677262 | Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammation |
| Q41866171 | High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance |
| Q36026612 | Higher blood hematocrit predicts hyperuricemia: a prospective study of 62,897 person-years of follow-up |
| Q37729894 | Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders. |
| Q51361299 | Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes. |
| Q82866771 | Hyperketonemia decreases mitochondrial membrane potential and its normalization with chromium (III) supplementation in monocytes |
| Q34665300 | Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes |
| Q35574642 | Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance |
| Q24647774 | IRS1-independent defects define major nodes of insulin resistance |
| Q37587810 | IRS1Ser³⁰⁷ phosphorylation does not mediate mTORC1-induced insulin resistance |
| Q58780551 | Impact of Obesity and Hyperglycemia on Placental Mitochondria |
| Q33779364 | Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats |
| Q38511940 | Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome |
| Q31075599 | Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. |
| Q54644240 | Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. |
| Q34370850 | Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients |
| Q46821621 | Impairment of brain mitochondrial charybdotoxin- and ATP-insensitive BK channel activities in diabetes |
| Q36315662 | Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. |
| Q41673379 | In Vivo Assessment of Mitochondrial Dysfunction in Clinical Populations Using Near-Infrared Spectroscopy |
| Q37577126 | In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion |
| Q36976994 | In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins |
| Q34627092 | Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance |
| Q36807542 | Increased daily walking improves lipid oxidation without changes in mitochondrial function in type 2 diabetes. |
| Q53812892 | Increased intramyocellular lipid/impaired insulin sensitivity is associated with altered lipid metabolic genes in muscle of high responders to a high-fat diet. |
| Q35757202 | Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle |
| Q43290988 | Increased susceptibility to oxidative damage in post-diabetic human myotubes |
| Q48459817 | Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. |
| Q39334553 | Insulin Resistance and Mitochondrial Dysfunction. |
| Q33556119 | Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation |
| Q43245108 | Insulin resistance and muscle metabolism in chronic kidney disease |
| Q31011189 | Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle |
| Q35776712 | Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans |
| Q37455082 | Insulin resistance of protein anabolism accompanies that of glucose metabolism in lean, glucose-tolerant offspring of persons with type 2 diabetes. |
| Q35783723 | Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function |
| Q30359509 | Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. |
| Q46817331 | Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise |
| Q33935397 | Integrative physiology: defined novel metabolic roles of osteocalcin. |
| Q44318860 | Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects |
| Q38204299 | Interference between concurrent resistance and endurance exercise: molecular bases and the role of individual training variables |
| Q50627211 | Intramuscular triglyceride content precedes impaired glucose metabolism without evidence for mitochondrial dysfunction during early development of a diabetic phenotype. |
| Q37572112 | Intrauterine diabetic milieu instigates dysregulated adipocytokines production in F1 offspring |
| Q42563623 | Irs1 serine 307 promotes insulin sensitivity in mice |
| Q28071388 | Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives |
| Q34576075 | Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study |
| Q34370958 | Lipid-induced insulin resistance: unravelling the mechanism |
| Q35648531 | Lipoamide Acts as an Indirect Antioxidant by Simultaneously Stimulating Mitochondrial Biogenesis and Phase II Antioxidant Enzyme Systems in ARPE-19 Cells |
| Q28568717 | Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway |
| Q38548983 | Liver mitochondrial function in ZDF rats during the early stages of diabetes disease. |
| Q43206562 | Liver-specific reduction of Mfn2 protein by RNAi results in impaired glycometabolism and lipid homeostasis in BALB/c mice |
| Q28473405 | Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria |
| Q34784839 | Low intrinsic running capacity is associated with reduced skeletal muscle substrate oxidation and lower mitochondrial content in white skeletal muscle |
| Q28533838 | Markers of skeletal muscle mitochondrial function and lipid accumulation are moderately associated with the homeostasis model assessment index of insulin resistance in obese men |
| Q34731075 | Maternal low-protein diet affects epigenetic regulation of hepatic mitochondrial DNA transcription in a sex-specific manner in newborn piglets associated with GR binding to its promoter |
| Q34305800 | Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. |
| Q37316256 | Maternal obesity reduces oxidative capacity in fetal skeletal muscle of Japanese macaques |
| Q44326667 | Maternal overnutrition programs changes in the expression of skeletal muscle genes that are associated with insulin resistance and defects of oxidative phosphorylation in adult male rat offspring. |
| Q35062009 | Measuring the acute effect of insulin infusion on ATP turnover rate in human skeletal muscle using phosphorus-31 magnetic resonance saturation transfer spectroscopy. |
| Q47296522 | Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice |
| Q34331776 | Mechanisms of insulin resistance in obesity |
| Q35854385 | Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function |
| Q39280816 | Metabolic Flexibility in Health and Disease |
| Q90176440 | Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin |
| Q36137196 | Metabolic Plasticity in Cancer Cells: Reconnecting Mitochondrial Function to Cancer Control |
| Q37420270 | Metabolic inflexibility during submaximal aerobic exercise is associated with glucose intolerance in obese older adults |
| Q27021552 | Metabolically healthy and unhealthy obese--the 2013 Stock Conference report |
| Q35825646 | Metformin mitigates the impaired development of skeletal muscle in the offspring of obese mice. |
| Q35976043 | Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome |
| Q37612965 | Mitochondria and diabetes mellitus: untangling a conflictive relationship? |
| Q28394886 | Mitochondria in the pathogenesis of diabetes: a proteomic view |
| Q37898562 | Mitochondrial DNA and inflammatory diseases. |
| Q89723737 | Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications |
| Q38645279 | Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance |
| Q34242002 | Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function |
| Q35057592 | Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. |
| Q41908246 | Mitochondrial complex I and V gene polymorphisms in type II diabetes mellitus among high risk Mizo-Mongoloid population, Northeast India |
| Q28304409 | Mitochondrial disease: powerhouse of disease |
| Q91179582 | Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes |
| Q34668089 | Mitochondrial dysfunction and insulin resistance: an update |
| Q38946122 | Mitochondrial dysfunction and its impact on diabetic heart |
| Q39005762 | Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies |
| Q28253498 | Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance |
| Q33766254 | Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action |
| Q33668501 | Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities |
| Q28390863 | Mitochondrial dysfunction in diabetic cardiomyopathy |
| Q49886209 | Mitochondrial dysfunction in diabetic kidney disease |
| Q36330418 | Mitochondrial dysfunction in insulin resistance: differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells |
| Q38126549 | Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? |
| Q35015797 | Mitochondrial dysfunction in patients with primary congenital insulin resistance |
| Q36330856 | Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice |
| Q37215415 | Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus |
| Q35607344 | Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions. |
| Q37059505 | Mitochondrial energetics and insulin resistance |
| Q37273337 | Mitochondrial fitness and insulin sensitivity in humans |
| Q37486050 | Mitochondrial function and dysfunction in exercise and insulin resistance |
| Q37482685 | Mitochondrial function and insulin resistance in overweight and normal-weight children |
| Q39501571 | Mitochondrial function assessed by 31P MRS and BOLD MRI in non-obese type 2 diabetic rats |
| Q55162945 | Mitochondrial function, content and ROS production in rat skeletal muscle: Effect of high-fat feeding |
| Q79721968 | Mitochondrial function: use it or lose it |
| Q36865626 | Mitochondrial inhibitor as a new class of insulin sensitizer |
| Q36703611 | Mitochondrial oxidative function and type 2 diabetes |
| Q90201900 | Mitochondrial oxidative phosphorylation is impaired in TALLYHO mice, a new obesity and type 2 diabetes animal model |
| Q36049068 | Mitochondrial oxidative phosphorylation is impaired in patients with congenital lipodystrophy |
| Q36953482 | Mitochondrial plasticity in obesity and diabetes mellitus |
| Q34022206 | Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity |
| Q37403358 | Mitochondrial respiratory capacity and content are normal in young insulin-resistant obese humans |
| Q58589370 | Moderate weight loss attenuates chronic endoplasmic reticulum stress and mitochondrial dysfunction in human obesity |
| Q38593252 | Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. |
| Q34774890 | Molecular correlates for maximal oxygen uptake and type 1 fibers |
| Q24632414 | Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction |
| Q34877773 | Molecular mechanisms of insulin resistance in type 2 diabetes mellitus |
| Q36906334 | Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle |
| Q37635807 | Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake |
| Q52336761 | NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis. |
| Q26996576 | New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond |
| Q37598306 | New insights into molecular mechanisms of diabetic kidney disease |
| Q36410694 | Novel and reversible mechanisms of smoking-induced insulin resistance in humans |
| Q36321634 | Novel biomarkers for pre-diabetes identified by metabolomics |
| Q44954152 | Novel role for thioredoxin reductase-2 in mitochondrial redox adaptations to obesogenic diet and exercise in heart and skeletal muscle |
| Q57012212 | Obesity and Diabetes: Lipotoxicity |
| Q37373479 | Obesity and T2DM in youth |
| Q38264223 | Obesity--a disease with many aetiologies disguised in the same oversized phenotype: has the overeating theory failed? |
| Q55286174 | Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress. |
| Q42820779 | Overexpression of LYRM1 induces mitochondrial impairment in 3T3-L1 adipocytes |
| Q24299984 | Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes |
| Q42471040 | Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids |
| Q39418956 | Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series |
| Q36570342 | Oxidative stress, insulin signaling, and diabetes. |
| Q24541524 | PGC-1 coactivators: inducible regulators of energy metabolism in health and disease |
| Q36825520 | PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle |
| Q46694910 | PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein |
| Q58195575 | PTMD: A Database of Human Disease-associated Post-translational Modifications |
| Q36139251 | Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo |
| Q37006469 | Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism |
| Q33812448 | Pathogenesis of insulin resistance in skeletal muscle |
| Q35676919 | Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle |
| Q35572930 | Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids |
| Q53720313 | Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes. |
| Q38104693 | Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes |
| Q37638746 | Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro |
| Q41886295 | Phosphatidylinositol 3,4,5-Trisphosphate Phosphatase SKIP Links Endoplasmic Reticulum Stress in Skeletal Muscle to Insulin Resistance |
| Q24337301 | Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1 |
| Q37736477 | Physiological insights gained from gene expression analysis in obesity and diabetes |
| Q37271487 | Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. |
| Q33668158 | Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study |
| Q28476486 | Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women |
| Q50988205 | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. |
| Q37143194 | Potential mechanisms of muscle mitochondrial dysfunction in aging and obesity and cellular consequences |
| Q54503216 | Progression of type 2 diabetes in GK rats affects muscle and liver mitochondria differently: pronounced reduction of complex II flux is observed in liver only. |
| Q36886235 | Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks |
| Q38155079 | Pulmonary arterial hypertension: challenges in translational research and a vision for change |
| Q37389002 | Quantitative proteomic and functional analysis of liver mitochondria from high fat diet (HFD) diabetic mice |
| Q36942945 | Race differences in the association of oxidative stress with insulin sensitivity in African- and European-American women |
| Q34468071 | Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity |
| Q39832067 | Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR |
| Q34489640 | Rats bred for low aerobic capacity become promptly fatigued and have slow metabolic recovery after stimulated, maximal muscle contractions |
| Q53704324 | Reduced Skeletal Muscle Phosphocreatine Concentration in Type 2 Diabetic Patients: A Quantitative Image-Based Phosphorus-31 MR Spectroscopy Study. |
| Q58722516 | Reduced expression of Twist 1 is protective against insulin resistance of adipocytes and involves mitochondrial dysfunction |
| Q37824851 | Regulation of endothelial function by mitochondrial reactive oxygen species |
| Q37716524 | Regulation of hepatic pyruvate dehydrogenase phosphorylation in offspring glucose intolerance induced by intrauterine hyperglycemia |
| Q28272571 | Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 |
| Q34119796 | Regulation of mitochondrial biogenesis |
| Q39389656 | Regulation of mitochondrial biogenesis by lipoprotein lipase in muscle of insulin-resistant offspring of parents with type 2 diabetes |
| Q34113727 | Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. |
| Q37599302 | Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus |
| Q36089550 | Relationship of oxidative stress in skeletal muscle with obesity and obesity-associated hyperinsulinemia in horses. |
| Q35837809 | Resistance Training in Type II Diabetes Mellitus: Impact on Areas of Metabolic Dysfunction in Skeletal Muscle and Potential Impact on Bone |
| Q47649709 | Respiromics - An integrative analysis linking mitochondrial bioenergetics to molecular signatures |
| Q47700908 | Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1. |
| Q55379110 | Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. |
| Q35450836 | Retinoid X receptor α overexpression alleviates mitochondrial dysfunction-induced insulin resistance through transcriptional regulation of insulin receptor substrate 1 |
| Q35991365 | Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes |
| Q41999664 | Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance |
| Q27028142 | Role of mitochondria in nonalcoholic fatty liver disease |
| Q37097807 | Role of mitochondrial dysfunction in insulin resistance |
| Q33924199 | Role of skeletal muscle mitochondrial density on exercise-stimulated lipid oxidation |
| Q41136392 | Roles of Fatty Acid oversupply and impaired oxidation in lipid accumulation in tissues of obese rats |
| Q48088509 | Rosmarinic Acid Mediates Mitochondrial Biogenesis in Insulin Resistant Skeletal Muscle Through Activation of AMPK. |
| Q33750699 | SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity |
| Q48002642 | SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK. |
| Q92354662 | Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship |
| Q92703384 | Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD |
| Q80080511 | Short-term activation of peroxysome proliferator-activated receptor beta/delta increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients |
| Q37193670 | Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes |
| Q54289083 | Similar changes in muscle lipid metabolism are induced by chronic high-fructose feeding and high-fat feeding in C57BL/J6 mice. |
| Q64111476 | Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function |
| Q26772781 | Skeletal Muscle Mitochondrial Bioenergetics and Morphology in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat Source |
| Q47215940 | Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node that Regulates Obesity-Induced Insulin Resistance. |
| Q45071737 | Skeletal muscle autophagy and mitophagy in endurance-trained runners before and after a high-fat meal. |
| Q36901521 | Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome |
| Q37624257 | Skeletal muscle insulin resistance is the primary defect in type 2 diabetes |
| Q36965630 | Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise |
| Q37463518 | Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. |
| Q51820293 | Stage of perinatal development regulates skeletal muscle mitochondrial biogenesis and myogenic regulatory factor genes with little impact of growth restriction or cross-fostering. |
| Q35086757 | Standard magnetic resonance-based measurements of the Pi→ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles |
| Q42825276 | Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity |
| Q37798716 | Systemic effects of white adipose tissue dysregulation and obesity-related inflammation |
| Q34454336 | Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. |
| Q36956731 | Targeting PGC-1 alpha to control energy homeostasis |
| Q51740135 | Targeting mitochondria as therapeutic strategy for metabolic disorders. |
| Q42555610 | The 6th Annual World Congress on the insulin resistance syndrome |
| Q55176253 | The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. |
| Q40300384 | The Genetic Basis of Type 2 Diabetes. |
| Q42686318 | The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. |
| Q52663276 | The Mitochondrial tRNALeu(UUR) A3302G Mutation may be Associated With Insulin Resistance in Woman With Polycystic Ovary Syndrome. |
| Q47138434 | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications. |
| Q94553871 | The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes |
| Q49971616 | The Role of Skeletal Muscle Estrogen Receptors in Metabolic Homeostasis and Insulin Sensitivity |
| Q54355769 | The activation of hepatic and muscle polyamine catabolism improves glucose homeostasis. |
| Q37055585 | The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study |
| Q36433751 | The coordination of nuclear and mitochondrial communication during aging and calorie restriction |
| Q89397680 | The impact of immobilisation and inflammation on the regulation of muscle mass and insulin resistance: different routes to similar end-points |
| Q36430696 | The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux |
| Q38845636 | The potential of endurance exercise-derived exosomes to treat metabolic diseases. |
| Q36482349 | The role of AMP-activated protein kinase in mitochondrial biogenesis |
| Q49906238 | The role of DNA-PK in aging and energy metabolism |
| Q36864744 | The role of estrogens in control of energy balance and glucose homeostasis |
| Q37606811 | The role of mitochondria in health and disease |
| Q37930956 | The role of mitochondria in insulin resistance and type 2 diabetes mellitus |
| Q36003367 | The role of mitochondria in the pathogenesis of type 2 diabetes |
| Q33779662 | The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance |
| Q37061247 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
| Q33942082 | The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. |
| Q35642128 | The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise |
| Q38121600 | Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? |
| Q30429437 | Total Skeletal Muscle PGC-1 Deficiency Uncouples Mitochondrial Derangements from Fiber Type Determination and Insulin Sensitivity |
| Q37335290 | Training Does Not Alter Muscle Ceramide and Diacylglycerol in Offsprings of Type 2 Diabetic Patients Despite Improved Insulin Sensitivity |
| Q55162907 | Transcriptional Metabolic Inflexibility in Skeletal Muscle Among Individuals With Increasing Insulin Resistance |
| Q46489599 | Troxerutin attenuates diet-induced oxidative stress, impairment of mitochondrial biogenesis and respiratory chain complexes in mice heart |
| Q58447602 | Type 2 diabetes mellitus |
| Q36764406 | Type II diabetes increases mitochondrial DNA mutations in the left ventricle of the Goto-Kakizaki diabetic rat. |
| Q40675125 | Unacylated ghrelin restores insulin and autophagic signaling in skeletal muscle of diabetic mice |
| Q39612792 | Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
| Q36144595 | Uteroplacental insufficiency leads to hypertension, but not glucose intolerance or impaired skeletal muscle mitochondrial biogenesis, in 12-month-old rats |
| Q50320399 | Wushenziye Formula Improves Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus via PTP1B-IRS1-Akt-GLUT4 Signaling Pathway. |
| Q59072672 | Zingiber officinale (Ginger): A Future Outlook on Its Potential in Prevention and Treatment of Diabetes and Prediabetic States |
| Q33646200 | miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway |
| Q36339596 | ³¹P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism |
| Q37810522 | β-Arrestins: multifunctional signaling adaptors in type 2 diabetes |
Search more.